This study confirms that further research assessing RET/PTC and THADA/IGF2BP3 rearrangements in suspicious thyroid nodules is necessary to improve patient management, particularly for deciding if a targeted therapy plan can be developed. This evidence concerns the gene IGF2BP3 and thyroid nodule.